BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12615374)

  • 1. Travellers' diarrhoea.
    Ericsson CD
    Int J Antimicrob Agents; 2003 Feb; 21(2):116-24. PubMed ID: 12615374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: prevention of travellers' diarrhoea.
    DuPont HL
    Aliment Pharmacol Ther; 2008 May; 27(9):741-51. PubMed ID: 18284650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Travellers' diarrhoea: contemporary approaches to therapy and prevention.
    DuPont HL
    Drugs; 2006; 66(3):303-14. PubMed ID: 16526819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: prevention and treatment of travellers' diarrhoea.
    Farthing MJ
    Aliment Pharmacol Ther; 1991 Feb; 5(1):15-30. PubMed ID: 1932478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of the use of rifaximin to prevent travellers' diarrhoea.
    Ng QX; Ho CYX; Shin D; Venkatanarayanan N; Chan HW
    J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
    DuPont HL; Steffen R
    J Travel Med; 2017 Apr; 24(suppl_1):S57-S62. PubMed ID: 28881862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.
    Layer P; Andresen V
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1155-64. PubMed ID: 20331580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea.
    Ericsson CD
    Drug Saf; 2006; 29(3):201-7. PubMed ID: 16524320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Travellers' diarrhoea: causes, prevention and treatment.
    Lloyd R; Bennett C
    Nurs Stand; 2012 Jun 6-12; 26(40):51-6; quiz 58. PubMed ID: 22848971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications for the prevention and treatment of travellers' diarrhea.
    Taylor DN; Hamer DH; Shlim DR
    J Travel Med; 2017 Apr; 24(suppl_1):S17-S22. PubMed ID: 28520998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
    DuPont HL; Steffen R
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27503854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: the epidemiology and clinical features of travellers' diarrhoea.
    DuPont HL
    Aliment Pharmacol Ther; 2009 Aug; 30(3):187-96. PubMed ID: 19392866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of travellers' diarrhoea.
    Caeiro JP; DuPont HL
    Drugs; 1998 Jul; 56(1):73-81. PubMed ID: 9664200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
    Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
    Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campylobacter jejuni proteomics for new travellers' diarrhoea vaccines.
    Schrotz-King P; Prokhorova TA; Nielsen PN; Crawford JS; Morsczeck C
    Travel Med Infect Dis; 2007 Mar; 5(2):106-9. PubMed ID: 17298916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo.
    Silberschmidt G; Schick MT; Steffen R; Kilpatrick ME; Murphy JR; Oyofo BA; el-Etr S; Gyurech D; Mourad AS; Mathewson JT
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):871-5. PubMed ID: 8574720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
    López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
    Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia.
    Kuenzli E; Juergensen D; Kling K; Jaeger VK; DeCrom S; Steffen R; Widmer AF; Battegay M; Hatz C; Neumayr A
    J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28931148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the Committee to Advise on Tropical Medicine and Travel (CATMAT) Statement on Travellers' Diarrhea.
    Libman M;
    Can Commun Dis Rep; 2015 Nov; 41(11):272-284. PubMed ID: 29769922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Travellers' diarrhoea.
    Steffen R; Boppart I
    Baillieres Clin Gastroenterol; 1987 Apr; 1(2):361-76. PubMed ID: 3311233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.